Chemomab Therapeutics Ltd. (CMMB) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-19 | 6-K | — | SEC |
| 2026-07-08 | 6-K | — | SEC |
| 2026-06-02 | 6-K | — | SEC |
| 2026-05-14 | 6-K | — | SEC |
| 2026-05-06 | 6-K | — | SEC |
| 2026-04-28 | 6-K | — | SEC |
| 2026-03-20 | 6-K | — | SEC |
| 2026-03-19 | 6-K | — | SEC |
| 2025-11-21 | 6-K | — | SEC |
| 2025-08-22 | 6-K | — | SEC |
| 2025-08-14 | 6-K | — | SEC |
| 2025-07-25 | 6-K | — | SEC |
| 2025-07-01 | 6-K | — | SEC |
| 2025-05-27 | 6-K | — | SEC |
| 2025-05-15 | 6-K | — | SEC |
| 2025-04-15 | 6-K | — | SEC |
| 2025-03-27 | 6-K | — | SEC |
| 2025-03-20 | 6-K | — | SEC |
| 2025-03-03 | 6-K | — | SEC |
| 2025-02-19 | 6-K | — | SEC |
| 2024-11-18 | 6-K | — | SEC |
| 2024-11-14 | 6-K | — | SEC |
| 2024-10-11 | 6-K | — | SEC |
| 2024-08-21 | 6-K | — | SEC |
| 2024-07-25 | 6-K | — | SEC |
| 2024-06-12 | 6-K | — | SEC |
| 2024-05-09 | 6-K | — | SEC |
| 2024-05-08 | 6-K | — | SEC |
| 2024-05-03 | 6-K | — | SEC |
| 2024-03-07 | 6-K | — | SEC |
| 2024-01-03 | 6-K | — | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.